reports
Moody's Ratings announces completion of a periodic review of ratings o...
Moody's Ratings (Moody's) has completed a periodic review of the ratings of Baxter International Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 17 June 2025 in which we reassessed the appropriateness of the ratings in the con...
Moody's Ratings upgrades Stryker Corporation to A3; revises outlook to...
Moody's Ratings (Moody's) upgraded Stryker Corporation's (Stryker) senior unsecured notes to A3 from Baa1, its senior unsecured shelf registration to (P)A3 from (P)Baa1, and its long term issuer rating to A3 from Baa1. At the same time, we affirmed Stryker's Prime-2 short-term commercial paper ratin...
Stryker Corp: 1 director
A director at Stryker Corp sold 1,241 shares at 388.560USD and the significance rating of the trade was 64/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...
Stryker declares an $0.84 per share quarterly dividend
Stryker declares an $0.84 per share quarterly dividend Portage, Michigan, May 08, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.84 per share payable July 31, 2025, to shareholders of record at the close of business on June 30, 2025, representing an increase of 5.0% versus the prior year and unchanged from the previous quarter. About Stryker Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in ...
Integra LifeSciences Reports First Quarter 2025 Financial Results
Integra LifeSciences Reports First Quarter 2025 Financial Results PRINCETON, N.J., May 05, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: IART), a leading global medical technology company, today reported financial results for the first quarter ending March 31, 2025. First Quarter 2025 Highlights First quarter revenues of $382.7 million increased 3.7% on a reported basis and decreased 3.5% on an organic basis compared to the prior year. First quarter GAAP earnings per diluted share of $(0.33), compared to $(0.04) in the prior year; adjusted earnings per diluted share of $0.41, compared to $0.55...
Stryker reports first quarter 2025 operating results
Stryker reports first quarter 2025 operating results Portage, Michigan, May 01, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the first quarter of 2025: First Quarter Results Reported net sales increased 11.9% to $5.9 billionOrganic net sales increased 10.1%Reported operating income margin of 14.3%Adjusted operating income margin(1) increased 100 bps to 22.9%Reported EPS decreased 17.6% to $1.69Adjusted EPS(1) increased 13.6% to $2.84 First Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions / Divestitures Org...
Stryker to participate in the Bank of America Securities 2025 Global H...
Stryker to participate in the Bank of America Securities 2025 Global Healthcare Conference Portage, Michigan, April 29, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the Bank of America Securities 2025 Global Healthcare Conference on Tuesday, May 13, 2025, at the Encore at Wynn Hotel in Las Vegas, Nevada. Representing the company will be Preston Wells, Vice President and Chief Financial Officer, and Jason Beach, Vice President, Finance and Investor Relations. Their presentation is scheduled for 1:40 p.m. Pacific Time. A live webcast and replay of the presentation will ...
Integra LifeSciences to Host First Quarter 2025 Financial Results Conf...
Integra LifeSciences to Host First Quarter 2025 Financial Results Conference Call on May 5, 2025 PRINCETON, N.J., April 18, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: IART), a leading global medical technology company, will release first quarter 2025 financial results on Monday, May 5, 2025, prior to the market open. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. ET. A live webcast will be available on the Investors section of the Company’s website at . For those planning to participate on the call, register to receive dial-in detail...
- Dave Nicoski
- Ross LaDuke
COP CONOCOPHILLIPS
SPTN SPARTANNASH CO
GE GENERAL ELECTRIC COMPANY
SLB.N SCHLUMBERGER NV
CNHI CNH INDUSTRIAL NV
WLDN WILLDAN GROUP
SIG SIGNET JEWELERS LIMITED
EVEREST RE GROUP LTD.
RDN RADIAN GROUP INC.
NSP INSPERITY INC.
NEU NEWMARKET CORPORATION
MOS MOSAIC COMPANY
MDLZ MONDELEZ INTERNATIONAL INC. CLASS A
LKQ LKQ CORPORATION
HOO HERBALIFE NUTRITION LTD.
HCA HCA HEALTHCARE INC
EEFT EURONET WORLDWIDE INC.
DVN DEVON ENERGY CORPORATION
DLTR DOLLAR TREE INC.
DG DOLLAR GENERAL CORPORATION
CTRE CARETRUST REIT INC
CROX CROCS INC.
BAX BAXTER INTERNATIONAL INC.
FDP FRESH DEL MONTE PRODUCE INC.
SJW SJW GROUP
EVTC EVERTEC INC.
POR PORTLAND GENERAL ELECTRIC COMPANY
YORW YORK WATER CO.
SEB SEABOARD CORP.
CELH CELSIUS HOLDINGS INC.
STNE STONECO
CMT COMPTON PETROLEUM CORP.
CNXC CONCENTRIX
Stryker to announce financial results for its first quarter of fiscal ...
Stryker to announce financial results for its first quarter of fiscal year 2025 Portage, Michigan, April 07, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for its first quarter of fiscal year 2025 on Thursday, May 1, 2025. A press release will be issued at approximately 4:05 p.m. ET and available at that day. The press release will include summary financial information for the company’s first quarter that ended March 31, 2025. Stryker will host a webcast at 4:30 p.m. ET on Thursday, May 1, 2025, to discuss its first quarter 2025 results. ...
Stryker completes sale of U.S. spinal implants business
Stryker completes sale of U.S. spinal implants business Portage, Michigan, April 01, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today that it has completed the sale of its U.S. spinal implants business to Viscogliosi Brothers, LLC, as part of the newly formed company VB Spine, LLC. “The sale of our spinal implants business enhances our strategic focus, positioning us to meet evolving customer needs and invest where we see the greatest opportunity for innovation and long-term growth,” said Kevin Lobo, Chair and CEO, Stryker. “We remain...
Stryker announces intention to nominate Manny Maceda to board of direc...
Stryker announces intention to nominate Manny Maceda to board of directors Portage, Michigan, March 26, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its board of directors has nominated Emmanuel “Manny” Maceda for election to the company’s board at the 2025 Annual Meeting of Shareholders, scheduled for May 8, 2025. Manny brings more than 30 years of experience leading high-performing organizations and advising senior executives on large-scale corporate transformations. He currently serves as Chairman of Bain & Company, following his tenure as Worldwide Managing Partner and...
Stryker announces Annual Meeting of Shareholders
Stryker announces Annual Meeting of Shareholders Portage, Michigan, March 25, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced its 2025 Annual Meeting of Shareholders is scheduled as follows: Thursday, May 8, 2025 – 9:30 a.m. Eastern Time The Meeting will be held virtually via the internet. Information about the webcast, which will include both the audio and the slide presentation from the meeting, is available on the Investor Relations page of our website at . To listen to the meeting as a guest dial (877) 328-2502 (U.S.) or (412) 317-5419 (International) and request the "Stryker...
Integra LifeSciences to Present at the Oppenheimer 35th Annual Healthc...
Integra LifeSciences to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference PRINCETON, N.J., March 13, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: IART), a leading global medical technology company, announced today that Mojdeh Poul, chief executive officer and Lea Knight, chief financial officer will present at the 35th Annual Oppenheimer Healthcare MedTech & Services Conference on March 17, 2025 at 10:00am ET. A live webcast of the presentation will be available on the Integra LifeSciences investor relations website at . About Integra LifeSciencesAt Integra LifeScien...
- Dave Nicoski
- Ross LaDuke
PMT PENNYMAC MORTGAGE INVESTMENT TRUST
BKD BROOKDALE SENIOR LIVING INC.
WBA WALGREENS BOOTS ALLIANCE INC
PLOW DOUGLAS DYNAMICS INC.
NSP INSPERITY INC.
NEU NEWMARKET CORPORATION
MDLZ MONDELEZ INTERNATIONAL INC. CLASS A
INTC INTEL CORPORATION
HSY HERSHEY COMPANY
DLTR DOLLAR TREE INC.
BMRN BIOMARIN PHARMACEUTICAL INC.
BAX BAXTER INTERNATIONAL INC.
SBL SAFE BULKERS INC.
CYH COMMUNITY HEALTH SYSTEMS INC.
LKO LAKES OIL N.L.
AWK AMERICAN WATER WORKS COMPANY INC.
CWT CALIFORNIA WATER SERVICE GROUP
TNC TENNANT COMPANY
NGVT INGEVITY CORPORATION
KALV KALVISTA PHARMACEUTICALS
SSTI SHOTSPOTTER
VIAC VIACOMCBS INC. CLASS B
STTK SHATTUCK LABS
CSTM CONSTELLIUM SE CLASS A
LUNG PULMONX
BBWI BATH & BODY WORKS INC
UWMC UWM HLDGS CORP
UDMY UDEMY INC
AMGN AMGEN INC
NYMT NEW YORK MORTGAGE TRUST INC.
HSHP HIMALAYA SHIPPING LTD.
PCH PICOMAT PLASTIC JSC
Integra LifeSciences Reports Fourth Quarter and Full-Year 2024 Financi...
Integra LifeSciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides 2025 Financial Guidance PRINCETON, N.J., Feb. 25, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: IART) today reported financial results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter 2024 Reported revenues were $442.6 million, representing an increase of 11.5% on a reported basis and an increase of 3.5% on an organic basis compared to the fourth quarter 2023. GAAP earnings per diluted share were $0.25, compared to $0.25 in the fourth quarter 2023. Adjusted earnings per dilut...
Stryker completes acquisition of Inari Medical, Inc., providing entry ...
Stryker completes acquisition of Inari Medical, Inc., providing entry into the high-growth peripheral vascular segment Portage, Michigan, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today that it has completed the acquisition of Inari Medical, Inc. (NASDAQ: NARI), a company that provides innovative solutions for venous thromboembolism (VTE) clot removal without the use of thrombolytic drugs. The addition of Inari brings an established peripheral vascular position to Stryker in the fast-growing VTE segment. “The acquisition of ...
Stryker to participate in Citi’s 2025 Unplugged Medtech and Life Scien...
Stryker to participate in Citi’s 2025 Unplugged Medtech and Life Sciences Access Day Portage, Michigan, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in Citi’s 2025 Unplugged Medtech and Life Sciences Access Day on Thursday, February 27, 2025 at Citigroup Headquarters, New York, New York. Stryker’s management will represent the Company in a presentation scheduled for 12:15 p.m. Eastern Time. A simultaneous webcast and replay of the Company’s presentation will be available on Stryker’s website at . The webcast will be archived on the Investor Relations page of th...
Stryker announces Allan Golston will retire from Board of Directors
Stryker announces Allan Golston will retire from Board of Directors Portage, Michigan, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced today that after 14 years of distinguished service, Allan Golston has notified the company that he will not stand for re-election at Stryker's 2025 Annual Meeting of Shareholders, which is expected to be held on May 8, 2025. Golston joined Stryker’s Board of Directors in 2011 and served as independent Lead Director from 2016 to 2022. He also served on the Governance and Nominating Committee and as Chair of the Compensation and Human Capita...
Stryker declares an $0.84 per share quarterly dividend
Stryker declares an $0.84 per share quarterly dividend Portage, Michigan, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.84 per share payable April 30, 2025 to shareholders of record at the close of business on March 31, 2025, representing an increase of 5.0% versus the prior year and unchanged from the previous quarter. About Stryker Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services i...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.